Mankind Pharma Limited has informed the Exchange about Link of Recording
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mankind Pharma has submitted a routine regulatory filing informing exchanges that the audio recording of their Q4 & FY26 investor conference call held on May 20, 2026 is now available on the company's website. This is a standard compliance filing under SEBI regulations requiring disclosure of investor communication materials. The actual content of the call (which may include management commentary, financial performance details, or guidance) is contained in the linked recording, not in this filing itself.
This filing is informational and does not contain standalone material information. Shareholders should access the linked recording to review any management commentary on Q4 and full-year FY26 performance that may influence the stock.